AAGH

America Great Health
OTC Markets OTCPKUSDEQUITY DELAYED
Last price
0.00
▼ 0.00 (33.33%)
MARKET ·

Price

Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
0.00
Prev close
0.00
Day high
0.00
Day low
0.00
Volume
5.10M
Market cap
P/E (TTM)
52W range
0.00 – 0.00

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
0.00% +1.4%
1M
+100.00% +96.3%
3M
+100.00% +96.9%
6M
+100.00% +88.9%
YTD
+100.00% +87.7%
1Y
-66.67% -86.7%
3Y
-95.00% -169.2%
5Y

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Free account

3 more panels on AAGH open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Fundamentals

TTM · reported
Market cap
Enterprise value
Revenue (TTM)
Gross profit
EBITDA
Net income
EPS (TTM)
Free cash flow
Total cash
Total debt
Book value / share
Shares outstanding
Float
Short % of float
Dividend yield
Beta (5Y)

Valuation & profitability ratios

Account required
Trailing P/E
Forward P/E
PEG ratio
Price / sales
Price / book
EV / revenue
EV / EBITDA
Gross margin
Operating margin
Profit margin
Return on equity
Return on assets
Debt / equity
Current ratio
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

As reported · 4 years · 6 quarters
Blank means not reported, not zero
Line item2025202420232022YoY
Total revenue $391.74K$294.67K$204.31K$104.65K +32.9%
Operating revenue $391.74K$294.67K$204.31K$104.65K +32.9%
Cost of revenue $52.62K$124.92K$35.72K$1.59M -57.9%
Gross profit $339.12K$169.75K$168.59K-$1.48M +99.8%
Selling, general & admin $722.06K$952.45K$661.23K$3.25M -24.2%
Total operating expense $722.06K$952.45K$661.23K$3.25M -24.2%
Operating income -$382.94K-$782.70K-$492.64K-$4.73M +51.1%
Net interest income -$338.31K-$443.66K-$319.68K-$190.91K +23.7%
Pre-tax income -$721.24K-$1.23M-$777.34K-$4.92M +41.2%
Net income -$719.12K-$1.22M-$761.42K-$4.87M +41.1%
Net income to common -$719.12K-$1.22M-$761.42K-$4.87M +41.1%
Basic EPS 0.000.000.00-0.00
Diluted EPS 0.000.000.00-0.00
EBIT -$382.89K-$782.64K-$457.63K-$4.73M +51.1%
EBITDA -$368.10K-$767.85K-$447.29K-$4.73M +52.1%
Basic shares 21.14B21.12B21.09B21.09B +0.1%
Diluted shares 21.14B21.12B21.09B21.09B +0.1%

Analyst targets & ownership

Account required
Mean target
High target
Low target
Implied upside
Analyst count
Consensus
Strong buy / Buy— / —
Hold
Sell / Strong sell— / —
Held by insiders
Held by institutions
Institutions holding
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
0.00
-16.67% from price
SMA 20
0.00
+11.11% from price
SMA 50
0.00
+31.58% from price
SMA 100
0.00
+57.48% from price
SMA 200
0.00
+76.21% from price
EMA 12
0.00
-11.54% from price
EMA 26
0.00
+6.99% from price
EMA 50
0.00
+25.44% from price
RSI (14)
51.7
Neutral
MACD (12,26,9)
0.00
Hist 0.00
ATR (14)
0.00
35.71% of price
Realised vol 30D
411.2%
Annualised
Bollinger upper
0.00
20, 2σ
Bollinger lower
0.00
20, 2σ
50 / 200 cross
Golden
0.00 vs 0.00
Trend bias
Above 200
+76.21%

Options chain

Account required
ExpirySpot 0.00
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
0.09
Less volatile than market
Correlation to SPY
0.00
Largely independent
Realised vol 30D
411.2%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-87.5%
Peak to trough
Max drawdown 5Y
-100.0%
Peak to trough
ATR 14
0.00
35.71% of price
Beta (reported)
5Y monthly, from filing

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.